Varex Imaging Corporation (NASDAQ: VREX) is a Healthcare company (Medical - Devices) with a market capitalization of $769M. The Maz Rating grades it against the other companies in its sector.
Varex Imaging Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $18.10, Varex Imaging Corporation trades at 34.5x trailing earnings, 0.9x sales and 1.5x book value, with an EV/EBITDA of 11.1. Over the last twelve months it generated about $863M of revenue and $22M of net income. It runs a gross margin of 34.3%, an operating margin of 8.3% and a net margin of 2.6%. It shows return on equity of 4.6%, return on invested capital of 6.4% and a free cash flow yield of -2.6%. On the balance sheet: a debt-to-equity ratio of 0.75 and a current ratio of 3.38. Over the past 52 weeks the share price ranged from $9.09 to $18.63, with a beta of 1.03.
Varex Imaging Corporation does not currently pay a dividend.
7 Wall Street analyst ratings cover the stock: 2 Buy and 5 Hold, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.